No current content.
Genevant Sciences is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, and decades of experience and expertise in nucleic acid drug delivery and development. Genevant leverages extensive nucleic acid drug delivery and development experience and expertise to develop new medicines for patients who need them. This is done by selectively collaborating with leading pharmaceutical and biotechnology companies who seek access to our platforms, technologies, systems and patent estate.
No current content.